Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
ORNIDAZOLE TABLET bulk supplier for pharma manufacturers

Ornidazole Tablet 500 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 500 mg

Reference Brands: -

Category: Antibiotics

Ornidazole 500 mg tablets, a single-ingredient nitroimidazole for amoebiasis, giardiasis, trichomoniasis and anaerobic infections. For importers, distributors, hospitals and tender buyers in markets where it is registered.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Ornidazole Tablet? List it or send an offer →

Product Description:

Ornidazole is a 5-nitroimidazole antimicrobial, in the same family as metronidazole and tinidazole. Inside anaerobic bacteria and protozoa its nitro group is reduced to reactive products that break microbial DNA, so it only works against organisms that thrive without oxygen. Its half-life is longer than metronidazole's, so fewer daily doses are needed. This page covers single-ingredient 500 mg film-coated tablets, distinct from the quinolone combinations sold widely in some markets.

It is used for intestinal and hepatic amoebiasis, giardiasis and trichomoniasis, and for anaerobic infections and their prevention around colorectal and gynaecological surgery. Trichomoniasis is often handled with a single larger dose, with sexual partners covered at the same time. Dizziness, headache and stomach upset are common. Long courses can cause peripheral neuropathy, which calls for stopping the drug. Labels advise avoiding it in early pregnancy and in nervous system disease. It enhances coumarin anticoagulants and prolongs vecuronium, so clotting tests and anaesthetic plans need attention.

Sourcing notes. Ornidazole is not approved by the US FDA but is registered in parts of Europe, Asia, Africa and Latin America, so check its status in your market first. A CTD or ACTD dossier with bioequivalence data and zone IVb stability is the usual requirement. Tablets are stored at room temperature, protected from light, in Alu-Alu or PVC/PVDC blisters. Insist on a CoA for each lot, a current GMP certificate and a CoPP. It is prescription-only.

Ornidazole Tablet — third party manufacturing & bulk supply

Ornidazole Tablet 500 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Ornidazole Tablet is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Ornidazole Tablet listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Ornidazole Tablet →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Ornidazole is used to treat infections caused by anaerobic bacteria and protozoa, including amoebiasis, giardiasis, trichomoniasis, and certain postoperative anaerobic infections. It works by damaging the DNA structure of microorganisms, leading to their elimination.

Ornidazole is a synthetic nitroimidazole derivative. Its structure contains a nitro group that becomes active inside susceptible organisms, disrupting their DNA and inhibiting growth.

Ornidazole is marketed under several trade names globally, with common ones including Dazolic and Ornida. Brand names may vary depending on the country and manufacturer.

Many other pharmaceutical companies in different regions also produce Ornidazole under various brand names. Other manufacturers, including some in India, also make it. Tell us your market and we will match you with suitable licensed makers.

The generic name of the product is ornidazole.

Common brand names include Dazolic, Ornida, and other region-specific brands depending on local manufacturers.

Production locations vary by company based on their approved facilities. Other manufacturers, including some in India, also make it. Tell us your market and we will match you with suitable licensed makers.

Related Products

Ofloxacin / Ornidazole Tablets

Strength:
200mg+ 500mg

Form: Tablets

Reference Brands: -

View Details
Nitazoxanide / Ofloxacin

Strength:
125mg+50mg

Form: Oral suspension

Reference Brands: -

View Details
Spiramycin Tablets

Strength:
3 MIU, 1.5MIU

Form: Tablets

Reference Brands: Rovamycine (EU/UK)

View Details
Ofloxacin / Ornidazol Suspension

Strength:
50mg+125mg

Form: Suspension

Reference Brands: -

View Details
Colistin (Polymyxin E) Inhalation Solution (Nebulizer)

Strength:
75 mg/2 mL

Form: Inhalation Solution (Nebulizer)

Reference Brands: Coly-Mycin M(US)

View Details
Azithromycin Intravenous

Strength:
500 mg/250 mL, 1000 mg/250 mL

Form: Intravenous (IV)

Reference Brands: Zithromax (US)

View Details
Amoxicillin Trihydrate Capsule

Strength:
250 mg, 500 mg, 875 mg, 1000 mg

Form: Tablets/Capsules/Powder for suspension

Reference Brands: Amoxil (US)

View Details
Cefdinir Suspension

Strength:
12mg/5ml / 250mg/5ml

Form: Oral Suspension

Reference Brands: Omnicef (US)

View Details
Enquire Now

Usually answered within 48 hours | GMP documents shared before you commit

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us